Royce & Associates’s Lexicon Pharmaceuticals LXRX Stock Holding History

Royce & Associates’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-12,344	Closed	-$18K	–	1023
2020 Q3	$18K	Buy	12,344 +1,135	+10%	+$2.02K	﹤0.01%	987
2020 Q2	$22K	Buy	11,209 +1,020	+10%	+$2K	﹤0.01%	1113
2020 Q1	$20K	Buy	10,189 +4,769	+88%	+$14.2K	﹤0.01%	1088
2019 Q4	$22K	Buy	+5,420	New	+$20.9K	﹤0.01%	1095
2016 Q2	–	Sell	-340,589	Closed	-$4.07M	–	1094
2016 Q1	$4.07M	Buy	340,589 +81,000	+31%	+$849K	0.03%	671
2015 Q4	$3.46M	Sell	259,589 -74,785	-22%	-$919K	0.02%	724
2015 Q3	$3.59M	Sell	334,374 -42,700	-11%	-$466K	0.02%	731
2015 Q2	$3.04M	Sell	377,074 -24,902	-6%	-$183K	0.01%	858
2015 Q1	$2.66M	Hold	401,976	–	–	0.01%	884
2014 Q4	$2.56M	Buy	401,976 +11,100	+3%	+$89.5K	0.01%	933
2014 Q3	$3.86M	Sell	390,876 -21,429	-5%	-$229K	0.01%	866
2014 Q2	$4.65M	Sell	412,305 -192,543	-32%	-$2.07M	0.01%	872
2014 Q1	$7.33M	Hold	604,848	–	–	0.02%	775
2013 Q4	$7.62M	Sell	604,848 -22,857	-4%	-$364K	0.02%	763
2013 Q3	$10.4M	Hold	627,705	–	–	0.03%	642
2013 Q2	$9.54M	Buy	+627,705	New	+$9.54M	0.03%	646

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return